Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD022920-03
Application #
3322866
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1988-09-01
Project End
1991-08-31
Budget Start
1990-09-01
Budget End
1991-08-31
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Lupu, F; Reed, E; McManus, P et al. (1992) Polymorphism and distribution of HLA-DR2 alleles in Romanians. Tissue Antigens 39:23-5
Reed, E; Lupu, F; McManus, P et al. (1992) Population and family studies of HLA-DR4 by use of oligonucleotide typing. Tissue Antigens 39:266-71
Harris, P E; Liu, Z; Suciu-Foca, N (1992) MHC class II binding of peptides derived from HLA-DR 1. J Immunol 148:2169-74
Reed, E; Ho, E; Lupu, F et al. (1992) Polymorphism of HLA in the Romanian population. Tissue Antigens 39:8-13
Suciu-Foca, N; Reed, E; D'Agati, V D et al. (1991) Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation 51:593-601
Reed, E; McManus, P; Suciu-Foca, N (1991) RFLP analysis of HLA-DR5 haplotypes. Tissue Antigens 37:66-73
Harris, P E; Gutierrez, M C; Reed, E et al. (1991) Biosynthesis and partial amino acid sequence of the human NDA4 antigen. An activation antigen common to B and T cell lineages. J Immunol 147:1299-306
Suciu-Foca, N; Reed, E; Marboe, C et al. (1991) The role of anti-HLA antibodies in heart transplantation. Transplantation 51:716-24
Suciu-Foca, N; Ho, E; King, D W et al. (1991) Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients. Transplant Proc 23:295-6
Harris, P; Reed, E; King, D W et al. (1991) In vitro studies of the effect of MAb NDA 4 linked to toxin on the proliferation of a human EBV-transformed lymphoblastoid B cell line and of gibbon MLA leukemia cell line. Cell Immunol 134:85-95

Showing the most recent 10 out of 13 publications